The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K.
Radar 91 (high attention) · dilution pressure high · listing risk high · governance risk high · runway 4.9 mo · strongest signal: Auditor change (Sep 18, 2026)
What would confirm: 424B5/8-K announcing an offering, ATM sales disclosed in next 10-Q, or Form 4 sales by insiders ahead of it.
What would prove it wrong: Non-dilutive cash event (asset sale, grant, milestone payment), OCF turning positive, or shelf withdrawn (RW).
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
Independent filings stitched into a thesis, each with what would confirm and what would prove it wrong.
The filings point to a discounted equity raise ahead — dilution for existing holders. Next thing to watch: a 424B or offering 8-K. Cash need (going concern in 8-k) coexists with live selling machinery (pipe). Base case is a discounted raise; the question is when, not if.
Listing is at risk and the usual cures are constrained. Next thing to watch: a reverse-split proxy, a hearings-panel 8-K, or a Form 25. Exchange deficiency plus a structural reason cure is hard (sub-$5M float, negative equity, no cash, or a reverse split already used). Under Nasdaq's 2026 rules (one reverse split per 12 months; $5M MVLS floor with no cure period from Sept 2026) the usual escape hatches are narrower.
No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 265 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
| Date | Signal | Evidence | Score |
|---|---|---|---|
| Sep 18, 2026 | ▼ Auditor change | 8-K Item 4.01 filed 2026-09-18 (accepted 16:27 ET) filing | 67 |
| Sep 18, 2026 | ▼ Going concern in 8-K | “going concern 8k” language in 8-K (8-K) filed 2026-09-18 filing | 31 |
| Sep 16, 2026 | ▼ PIPE | “pipe” language in 8-K (EX-10.1) filed 2026-09-16 filing | 38 |
| Sep 16, 2026 | ▼ Unregistered sale | 8-K Item 3.02 filed 2026-09-16 (accepted 08:30 ET) filing | 32 |
| Sep 16, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (EX-10.1) filed 2026-09-16 filing | 32 |
| Sep 8, 2026 | ▼ Minimum bid deficiency | “min bid” language in 8-K (EX-99.1) filed 2026-09-08 filing | 42 |
| Sep 8, 2026 | ▼ Reverse split | “reverse split” language in 8-K (8-K) filed 2026-09-08 filing | 40 |
| Sep 8, 2026 | ▼ Holder rights modified | 8-K Item 3.03 filed 2026-09-08 (accepted 08:30 ET) filing | 24 |
| Aug 25, 2026 | ▼ Exchange deficiency notice | 8-K Item 3.01 filed 2026-08-25 (accepted 19:25 ET) filing | 52 |
| Aug 25, 2026 | ▼ Delisting language | “delisting notice” language in 8-K (8-K) filed 2026-08-25 filing | 47 |
| Dec 31, 2025 | ▼ Share count +25% | Shares outstanding 1,616,081 (2026-06-04) -> 2,108,277 (2026-07-31), +30% filing | 34 |
| Dec 31, 2025 | ▼ Negative equity | Stockholders' equity $-8,812,688 as of 2026-03-31 filing | 31 |
| Dec 31, 2025 | ▼ Runway < 6 months | ~4.9 months runway: liquidity $3,086,770 as of 2025-12-31, burn $7,528,859/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing | 29 |
| Dec 31, 2025 | ▼ Cash < current liabilities | Liquidity $3,086,770 vs current liabilities $12,063,261 filing | 22 |
SDST Stardust Power Inc. · GOVX GeoVax Labs, Inc. · MYSZ My Size, Inc. · SNTI Senti Biosciences Holdings, · GCTK Glucotrack, Inc. · SOAR Volato Group, Inc. · screener →